statistiche ricercatore

Continente	#
AS - Asia	428
NA - Nord America	323
EU - Europa	273
SA - Sud America	34
Continente sconosciuto - Info sul continente non disponibili	33
AF - Africa	23
OC - Oceania	1
Totale	1.115

Nazione	#
US - Stati Uniti d'America	316
SG - Singapore	161
CN - Cina	102
VN - Vietnam	73
IT - Italia	66
HK - Hong Kong	35
FI - Finlandia	30
SE - Svezia	29
DE - Germania	27
BR - Brasile	25
NL - Olanda	23
GB - Regno Unito	20
IE - Irlanda	19
FR - Francia	18
RU - Federazione Russa	13
IN - India	12
KR - Corea	12
TG - Togo	12
JP - Giappone	10
AR - Argentina	8
ES - Italia	6
AT - Austria	5
CI - Costa d'Avorio	5
BD - Bangladesh	4
JO - Giordania	4
PH - Filippine	3
TH - Thailandia	3
ZA - Sudafrica	3
BE - Belgio	2
BS - Bahamas	2
CZ - Repubblica Ceca	2
ID - Indonesia	2
KE - Kenya	2
MX - Messico	2
PT - Portogallo	2
SA - Arabia Saudita	2
TR - Turchia	2
UA - Ucraina	2
AO - Angola	1
AU - Australia	1
BG - Bulgaria	1
CA - Canada	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
GR - Grecia	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
LU - Lussemburgo	1
LV - Lettonia	1
MD - Moldavia	1
PK - Pakistan	1
PL - Polonia	1
PR - Porto Rico	1
PY - Paraguay	1
RO - Romania	1
TW - Taiwan	1
Totale	1.082

Nome	#
Normative data for COGITAB: An Italian tablet-based test battery conceived for the preclinical phase of Alzheimer's disease	217
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial	149
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial	141
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells	129
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis	117
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL)	113
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: still a potential druggable target?	106
Synergistic inhibition of FLT3-ITD acute myeloid leukaemia cell growth in vitro using combination of FLT3 inhibitor quizartinib and standard of care chemotherapeutic agent cytarabine	89
Efficacy and Safety of Accelerated Cornea Cross-linking for Progressive Keratoconus: A 5-Year Follow-up Study	54
Totale	1.115

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	96	0	0	5	0	7	1	0	26	5	8	20	24
2022/2023	151	9	24	7	11	9	9	9	9	35	6	12	11
2023/2024	35	5	8	2	3	7	2	4	2	1	1	0	0
2024/2025	269	16	34	17	17	48	13	27	6	1	26	12	52
2025/2026	525	50	45	40	43	69	42	53	34	90	38	13	8
2026/2027	12	12	0	0	0	0	0	0	0	0	0	0	0
Totale													1.115

CRIS Current Research Information System